QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ARWR

QT60Arrowhead Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
81.82
+0.78+0.96%
OverviewShort InterestFilings
ARWRQT60Arrowhead Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
81.82+0.96%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 17, 2026Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 2026Jun 17, 20263Initial statement of beneficial ownership
Jun 16, 2026Jun 16, 20268-KCurrent report
May 14, 2026May 14, 20264Statement of changes in beneficial ownership
May 07, 2026May 07, 2026S-8Registration of employee benefit securities
May 07, 2026May 07, 20268-KCurrent report
May 07, 2026May 07, 202610-QQuarterly report
May 06, 2026May 06, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 2026Apr 28, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 2026Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 2026Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 2026Apr 24, 2026SC 13G/ASC 13G/A
Mar 26, 2026Mar 26, 2026SC 13G/ASC 13G/A
Mar 20, 2026Mar 20, 20268-KCurrent report
Mar 09, 2026Mar 09, 20264Statement of changes in beneficial ownership
Feb 05, 2026Feb 05, 202610-QQuarterly report
Feb 05, 2026Feb 05, 20268-KCurrent report
Jan 27, 2026Jan 27, 2026DEFA14AAdditional proxy soliciting materials
Jan 27, 2026Jan 27, 2026DEF 14ADefinitive proxy statement
Jan 27, 2026Jan 27, 2026ARSARS
Jan 21, 2026Jan 21, 2026SC 13G/ASC 13G/A
Jan 12, 2026Jan 12, 20268-KCurrent report
Jan 09, 2026Jan 09, 2026424B5424B5
Jan 09, 2026Jan 09, 2026424B5424B5
#1 / 25 of 284
Page
▼
/ 12